Annual Retained Earnings
-$679.35 M
-$102.24 M-17.72%
December 31, 2023
Summary
- As of February 22, 2025, URGN annual retained earnings is -$679.35 million, with the most recent change of -$102.24 million (-17.72%) on December 31, 2023.
- During the last 3 years, URGN annual retained earnings has fallen by -$322.85 million (-90.56%).
- URGN annual retained earnings is now -2588.04% below its all-time high of -$25.27 million, reached on December 31, 2015.
Performance
URGN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$768.71 M
-$23.67 M-3.18%
September 30, 2024
Summary
- As of February 22, 2025, URGN quarterly retained earnings is -$768.71 million, with the most recent change of -$23.67 million (-3.18%) on September 30, 2024.
- Over the past year, URGN quarterly retained earnings has dropped by -$115.38 million (-17.66%).
- URGN quarterly retained earnings is now -2724.69% below its all-time high of -$27.21 million, reached on December 31, 2016.
Performance
URGN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
URGN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.7% | -17.7% |
| 3 y3 years | -90.6% | -75.2% |
| 5 y5 years | -452.9% | -306.6% |
URGN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.4% | at low | -64.5% | at low |
| 5 y | 5-year | -197.9% | at low | -237.1% | at low |
| alltime | all time | -2588.0% | at low | -2724.7% | at low |
UroGen Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$768.71 M(+3.2%) |
| Jun 2024 | - | -$745.04 M(+4.7%) |
| Mar 2024 | - | -$711.63 M(+4.8%) |
| Dec 2023 | -$679.35 M(+17.7%) | -$679.35 M(+4.0%) |
| Sep 2023 | - | -$653.33 M(+3.5%) |
| Jun 2023 | - | -$631.45 M(+4.0%) |
| Mar 2023 | - | -$607.32 M(+5.2%) |
| Dec 2022 | -$577.10 M(+23.5%) | -$577.10 M(+5.3%) |
| Sep 2022 | - | -$548.24 M(+4.9%) |
| Jun 2022 | - | -$522.40 M(+5.4%) |
| Mar 2022 | - | -$495.71 M(+6.1%) |
| Dec 2021 | -$467.32 M(+31.1%) | -$467.32 M(+6.5%) |
| Sep 2021 | - | -$438.87 M(+7.4%) |
| Jun 2021 | - | -$408.66 M(+6.9%) |
| Mar 2021 | - | -$382.44 M(+7.3%) |
| Dec 2020 | -$356.50 M | -$356.50 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$325.98 M(+9.7%) |
| Jun 2020 | - | -$297.16 M(+11.8%) |
| Mar 2020 | - | -$265.81 M(+16.6%) |
| Dec 2019 | -$228.02 M(+85.6%) | -$228.02 M(+20.6%) |
| Sep 2019 | - | -$189.04 M(+13.3%) |
| Jun 2019 | - | -$166.79 M(+15.6%) |
| Mar 2019 | - | -$144.31 M(+17.5%) |
| Dec 2018 | -$122.87 M(+160.2%) | -$122.87 M(+23.9%) |
| Sep 2018 | - | -$99.15 M(+26.1%) |
| Jun 2018 | - | -$78.62 M(+29.7%) |
| Mar 2018 | - | -$60.60 M(+28.3%) |
| Dec 2017 | -$47.21 M(+73.5%) | -$47.21 M(+27.2%) |
| Sep 2017 | - | -$37.13 M(+0.8%) |
| Jun 2017 | - | -$36.83 M(+35.3%) |
| Dec 2016 | -$27.21 M(+7.7%) | -$27.21 M |
| Dec 2015 | -$25.27 M | - |
FAQ
- What is UroGen Pharma annual retained earnings?
- What is the all time high annual retained earnings for UroGen Pharma?
- What is UroGen Pharma annual retained earnings year-on-year change?
- What is UroGen Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for UroGen Pharma?
- What is UroGen Pharma quarterly retained earnings year-on-year change?
What is UroGen Pharma annual retained earnings?
The current annual retained earnings of URGN is -$679.35 M
What is the all time high annual retained earnings for UroGen Pharma?
UroGen Pharma all-time high annual retained earnings is -$25.27 M
What is UroGen Pharma annual retained earnings year-on-year change?
Over the past year, URGN annual retained earnings has changed by -$102.24 M (-17.72%)
What is UroGen Pharma quarterly retained earnings?
The current quarterly retained earnings of URGN is -$768.71 M
What is the all time high quarterly retained earnings for UroGen Pharma?
UroGen Pharma all-time high quarterly retained earnings is -$27.21 M
What is UroGen Pharma quarterly retained earnings year-on-year change?
Over the past year, URGN quarterly retained earnings has changed by -$115.38 M (-17.66%)